Impact of in vitro SARS-CoV-2 infection on breast cancer cells 
Some cancer cells may exhibit a higher SarsCoV2 tropism potentializing agressiveness
"Since we found that the estrogen receptor breast cancer cell line MCF7 was the most permissive to virus replication, it would be possible to imagine a scenario in which estrogen receptor positive breast tumors may act as a sort of SARS-CoV-2 reservoir that can continuously supplies new viral particles thus exacerbating COVID-19 aggressiveness and the consequences associated to this disease."
"As SARS-CoV-2 still spreads among the population, it is essential to understand the impact of SARS-CoV-2 infection on breast cancer, particularly in premenopausal patients diagnosed with the luminal A subtype, and to assess the long-term impact of COVID-19 on breast cancer outcomes." nature.com/articles/s4159